Is UNCY or URGN more undervalued in 2026?

CirclFi compares Unicycive Therapeutics, Inc. (UNCY) and UroGen Pharma Ltd. (URGN) using 13 institutional-grade valuation models. UNCY has a Quality of Company score of 4.3/10 while URGN scores 6.5/10.

Which is a better buy — UNCY or URGN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do UNCY and URGN valuations compare?

UNCY at $7.02 and URGN at $28.69 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

UNCY vs URGN Valuation Comparison 2026 — Intrinsic Value Analysis

UNCY

Biotechnology

Unicycive Therapeutics, Inc.

Quality

4.3

out of 10

Value Trap

LOW

Price

$7.02

Last close

Models

9/13

Active

URGN

Biotechnology

UroGen Pharma Ltd.

Quality

6.5

out of 10

Value Trap

SAFE

Price

$28.69

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	UNCY Fair Value	UNCY Upside	URGN Fair Value	URGN Upside
Bayesian DCF	Intrinsic	$2.65	-62.3%	$7.27	-74.7%
Earnings Power Value	Intrinsic	—	—	$3.35	-85.4%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$0.56	-92.7%	—	—
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for UNCY vs URGN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

UNCY vs URGN — Which Stock Is More Undervalued?

URGN scores higher with a 6.5/10 quality rating vs UNCY's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Unicycive Therapeutics, Inc. (UNCY) and UroGen Pharma Ltd. (URGN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

UNCY currently trades at $7.02 with a QOC of 4.3/10, while URGN trades at $28.69 with a QOC of 6.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).